|
Kilitch Drugs(I) Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
597.23 Cr.
|
P/BV
|
2.37
|
Book Value (Rs.)
|
144.30
|
|
52 Week High/Low (Rs.)
|
500/305
|
FV/ML
|
10/1
|
P/E(X)
|
22.37
|
|
Bookclosure
|
15/07/2025
|
EPS (Rs.)
|
15.27
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 16.60 | 9.17 | 6.71 | 4.73 | 2.37 |
| Diluted EPS (Rs.) | 16.60 | 9.17 | 6.71 | 4.73 | 2.37 |
| Cash EPS (Rs.) | 17.44 | 10.52 | 7.59 | 5.57 | 3.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 125.81 | 109.62 | 96.64 | 90.03 | 83.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 125.81 | 109.62 | 96.64 | 90.03 | 83.56 |
| Revenue From Operations / Share (Rs.) | 123.31 | 95.99 | 89.59 | 73.31 | 44.22 |
| PBDIT / Share (Rs.) | 26.50 | 17.80 | 13.15 | 8.52 | 5.07 |
| PBIT / Share (Rs.) | 24.57 | 15.72 | 10.87 | 6.94 | 3.79 |
| PBT / Share (Rs.) | 21.44 | 12.03 | 7.71 | 6.17 | 3.30 |
| Net Profit / Share (Rs.) | 15.51 | 8.44 | 5.32 | 3.99 | 2.43 |
| NP After MI And SOA / Share (Rs.) | 16.60 | 9.08 | 6.71 | 4.73 | 2.37 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 21.49 | 18.54 | 14.67 | 11.62 | 11.47 |
| PBIT Margin (%) | 19.92 | 16.37 | 12.12 | 9.46 | 8.57 |
| PBT Margin (%) | 17.38 | 12.53 | 8.60 | 8.41 | 7.47 |
| Net Profit Margin (%) | 12.57 | 8.79 | 5.93 | 5.43 | 5.49 |
| NP After MI And SOA Margin (%) | 13.46 | 9.45 | 7.48 | 6.44 | 5.35 |
| Return on Networth / Equity (%) | 13.19 | 8.28 | 6.89 | 5.29 | 2.88 |
| Return on Capital Employeed (%) | 17.29 | 14.37 | 11.24 | 7.69 | 4.52 |
| Return On Assets (%) | 8.53 | 6.08 | 4.75 | 3.51 | 1.80 |
| Long Term Debt / Equity (X) | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.24 | 0.17 | 0.14 | 0.14 | 0.11 |
| Asset Turnover Ratio (%) | 0.71 | 0.67 | 0.65 | 0.48 | 0.41 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.06 | 2.27 | 1.84 | 1.65 | 1.10 |
| Quick Ratio (X) | 1.88 | 2.21 | 1.81 | 1.57 | 1.05 |
| Inventory Turnover Ratio (X) | 20.55 | 51.18 | 21.16 | 14.04 | 8.31 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 8.46 | 4.83 | 4.16 | 11.08 | 10.42 |
| Interest Coverage Ratio (Post Tax) (%) | 5.95 | 3.29 | 2.68 | 6.18 | 5.99 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 619.00 | 638.35 | 218.65 | 272.89 | 130.24 |
| EV / Net Operating Revenue (X) | 3.12 | 4.14 | 1.57 | 2.39 | 1.90 |
| EV / EBITDA (X) | 14.52 | 22.29 | 10.67 | 20.55 | 16.57 |
| MarketCap / Net Operating Revenue (X) | 2.93 | 4.06 | 1.56 | 2.29 | 1.83 |
| Price / BV (X) | 2.87 | 3.56 | 1.43 | 1.88 | 0.98 |
| Price / Net Operating Revenue (X) | 2.93 | 4.06 | 1.56 | 2.29 | 1.83 |
| EarningsYield | 0.04 | 0.02 | 0.04 | 0.02 | 0.02 |
